Hydroxyzine is a first-generation antihistamine commonly prescribed in syrup form to infants and young children with itch-inducing skin conditions, such as atopic dermatitis and eczema. New research shows that the more hydroxyzine a child is prescribed, the higher their risk for developing a tic, anxiety, or conduct disorder.
Welcome to this month’s Research Roundup, a recurring overview of recent studies published by researchers at BC Children’s Hospital Research Institute (BCCHR) and the University of British Columbia, and their collaborators.
The chemotherapy drug cisplatin is an effective cancer treatment for many children with the disease, but it can also cause permanent hearing loss. Results from a new study show that the hearing of very young children is impacted early during treatment and is affected to a greater extent than that of older children. This is…
For Media
Every day, our researchers are working towards breakthroughs to transform the lives of kids in British Columbia and around the world. Learn about the latest innovations and advancements in child health.